Latest Insider Transactions at Benitec Biopharma Inc. (BNTC)
This section provides a real-time view of insider transactions for Benitec Biopharma Inc. (BNTC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Benitec Biopharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Benitec Biopharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2024
|
Suvretta Capital Management, LLC |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
7,137,763
+26.4%
|
$7,137,763
$1.93 P/Share
|
|
Aug 11
2023
|
J Kevin Buchi Director |
BUY
Open market or private purchase
|
Direct |
51,813
+49.86%
|
-
|
|
Aug 11
2023
|
Megan Boston Executive Director |
BUY
Open market or private purchase
|
Direct |
25,907
+50.0%
|
-
|
|
Dec 09
2021
|
Steven Michael Oliveira > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,553
+1.04%
|
$31,659
$3.04 P/Share
|
|
Nov 29
2021
|
Steven Michael Oliveira > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,947
+3.69%
|
$113,841
$3.18 P/Share
|
|
May 03
2021
|
Steven Michael Oliveira > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,500
+4.08%
|
$162,000
$4.25 P/Share
|
|
Apr 30
2021
|
Steven Michael Oliveira > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
120,000
+11.64%
|
$480,000
$4.18 P/Share
|
|
Apr 29
2021
|
Steven Michael Oliveira > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,877
+2.81%
|
$114,385
$5.49 P/Share
|
|
Apr 28
2021
|
Steven Michael Oliveira > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+11.52%
|
$500,000
$5.45 P/Share
|